qPCR Assay for Detection of JC Virus

Description:
JC Virus causes a fatal disease in the brain called progressive multifocal leukoencephalopathy (PML) that occurs in many patients with immunocompromised conditions. For example, more than five percent (5%) of AIDS patients develop PML. Additionally, these conditions include, but are not limited to, cancers such as leukemias and lymphomas, organ transplants such as kidney, heart and autoimmune conditions with treatment that modulates the immune system such as Multiple Sclerosis (MS), rheumatoid arthritis, psoriasis, and systemic lupus erythematosus. The finding of JCV DNA in the patients with neurological symptoms of PML is a diagnostic criterion and is needed to confirm the diagnosis of PML to rule out other neurological conditions.

This technology describes a qPCR assay that utilizes viral DNA standards and testing samples to detect the presence of the JC viral genome in patients' cerebrospinal fluid and blood, blood products, and tissue samples from biopsy or autopsy.
Patent Information:
For Information, Contact:
Susan Ano
Technology Development Coordinator
NIH Technology Transfer
301-435-5515
susan.ano@nih.gov
Inventors:
Caroline Ryschkewitsch
Eugene Major
Keywords:
assay
DA4BXX
DA4XXX
DAXXXX
DDXXXX
Detection
DEXXXX
DNA
DXXXXX
JC
Proficiency
Progressive multifocal leukoencephalopathy
QPCR
Samples'
STANDARDS
Systemic lupus erythematosus
test
virus
© 2024. All Rights Reserved. Powered by Inteum